You have 9 free searches left this month | for more free features.

Stage I - II primary lung cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage I - II Primary Lung Cancer, Stage I Lung Cancer, Stage II Lung Cancer Trial in Boston (AveCure 16 Gauge Flexible Microwave

Not yet recruiting
  • Stage I - II Primary Lung Cancer
  • +5 more
  • AveCure 16 Gauge Flexible Microwave Ablation Probe
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 11, 2022

NSCLC, Stage I Trial in United States (Pembrolizumab)

Recruiting
  • NSCLC, Stage I
  • Tampa, Florida
  • +10 more
Dec 12, 2022

Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Lung Trial in Chicago (procedure, other,

Not yet recruiting
  • Lung Carcinoma
  • +5 more
  • Computed Tomography
  • +6 more
  • Chicago, Illinois
    Northwestern University
Mar 24, 2023

NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Milano, Italy
  • +12 more
Dec 14, 2022

Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

Not yet recruiting
  • Limited Stage Lung Small Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Nov 10, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +6 more
  • Biopsy
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 6, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Lung Cancer, Carcinoma, Non-Small Cell Lung Trial in Omaha (consolidative hypofractionated radiation therapy (hfRT), Durvalumab

Recruiting
  • Lung Cancer
  • Carcinoma, Non-Small Cell Lung
  • consolidative hypofractionated radiation therapy (hfRT)
  • Durvalumab 50 MG/ML
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jul 27, 2021

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022

Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

Recruiting
  • Esophageal Carcinoma
  • +16 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)

Completed
  • Lung Cancer
  • Metastatic Cancer
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Oct 29, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • (no location specified)
May 24, 2022

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +8 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Pulmonary Artery-First Surgical Technique
  • Biospecimen Collection
  • (no location specified)
Aug 15, 2022

Non-metastatic, Non-recurrent Lung and Esophageal Cancer

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +55 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 5, 2023

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte (Quality-of-Life

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +21 more
  • Quality-of-Life Assessment
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

Terminated
  • Mesothelin Positive
  • +4 more
  • Anetumab Ravtansine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jan 5, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Non Small Cell Lung Cancer, Secondary Lung Cancer Trial in Salt Lake City (Personalized Exercise Program)

Completed
  • Non Small Cell Lung Cancer
  • Secondary Lung Cancer
  • Personalized Exercise Program
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 9, 2022